🚀 VC round data is live in beta, check it out!

AiN Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for AiN Group and similar public comparables like Create SD Holdings, Redcare Pharmacy, Selçuk Ecza, Yixintang Pharmaceutical and more.

AiN Group Overview

About AiN Group

Ain Holdings Inc's core business is the dispensing pharmacy business that includes preparing and dispensing drugs based on prescriptions. The company also generates revenue by selling generic drugs wholesale, pharmacy staffing services, and pharmacy consulting services. The company’s additional business activity includes both urban and suburban drug and cosmetic stores. Ain operates the ainz & tuple brand that specifically targets female consumers in urban areas. The company also executes small real estate rental strategies.


Founded

1969

HQ

Japan

Employees

9.8K

Website

ainj.co.jp

Sectors

Financials (LTM)

Revenue: $4B
EBITDA: $307M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

AiN Group Financials

AiN Group reported last 12-month revenue of $4B and EBITDA of $307M.

In the same LTM period, AiN Group generated $654M in gross profit, $307M in EBITDA, and $83M in net income.

Revenue (LTM)


AiN Group P&L

In the most recent fiscal year, AiN Group reported revenue of $3B and EBITDA of $214M.

AiN Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See AiN Group forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$4BXXX$3BXXXXXXXXX
Gross Profit$654MXXX$468MXXXXXXXXX
Gross Margin17%XXX15%XXXXXXXXX
EBITDA$307MXXX$214MXXXXXXXXX
EBITDA Margin8%XXX7%XXXXXXXXX
EBIT Margin4%XXX4%XXXXXXXXX
Net Profit$83MXXX$64MXXXXXXXXX
Net Margin2%XXX2%XXXXXXXXX
Net Debt——$74MXXXXXXXXX

Financial data powered by Morningstar, Inc.

AiN Group Stock Performance

AiN Group has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


AiN Group's stock price is $38.83.

See AiN Group trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B0.1%XXXXXXXXX$1.82

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

AiN Group Valuation Multiples

AiN Group trades at 0.4x EV/Revenue multiple, and 4.7x EV/EBITDA.

See valuation multiples for AiN Group and 15K+ public comps

EV / Revenue (LTM)


AiN Group Financial Valuation Multiples

As of March 19, 2026, AiN Group has market cap of $1B and EV of $1B.

Equity research analysts estimate AiN Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

AiN Group has a P/E ratio of 16.4x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$1BXXX$1BXXXXXXXXX
EV/Revenue0.4xXXX0.5xXXXXXXXXX
EV/EBITDA4.7xXXX6.7xXXXXXXXXX
EV/EBIT8.3xXXX12.3xXXXXXXXXX
EV/Gross Profit2.2xXXX3.1xXXXXXXXXX
P/E16.4xXXX21.3xXXXXXXXXX
EV/FCF(2.3x)XXX20.8xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified AiN Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

AiN Group Margins & Growth Rates

AiN Group's revenue in the last 12 month grew by 14%.

AiN Group's revenue per employee in the last FY averaged $0.4M.

AiN Group's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AiN Group's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for AiN Group and other 15K+ public comps

AiN Group Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth14%XXX29%XXXXXXXXX
EBITDA Margin8%XXX7%XXXXXXXXX
EBITDA Growth16%XXX49%XXXXXXXXX
Rule of 40—XXX22%XXXXXXXXX
Bessemer Rule of X—XXX42%XXXXXXXXX
Revenue per Employee—XXX$0.4MXXXXXXXXX
S&M Expenses to Revenue—XXX1%XXXXXXXXX
G&A Expenses to Revenue—XXX0%XXXXXXXXX
Opex to Revenue—XXX12%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

AiN Group Public Comps

See public comps and valuation multiples for other Pharmacies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Create SD HoldingsXXXXXXXXXXXXXXXXXX
Redcare PharmacyXXXXXXXXXXXXXXXXXX
Selçuk EczaXXXXXXXXXXXXXXXXXX
Yixintang PharmaceuticalXXXXXXXXXXXXXXXXXX
Anhui Huaren HealthXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

AiN Group M&A Activity

AiN Group acquired XXX companies to date.

Last acquisition by AiN Group was on XXXXXXXX, XXXXX. AiN Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by AiN Group

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

AiN Group Investment Activity

AiN Group invested in XXX companies to date.

AiN Group made its latest investment on XXXXXXXX, XXXXX. AiN Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by AiN Group

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About AiN Group

When was AiN Group founded?AiN Group was founded in 1969.
Where is AiN Group headquartered?AiN Group is headquartered in Japan.
How many employees does AiN Group have?As of today, AiN Group has over 9K employees.
Is AiN Group publicly listed?Yes, AiN Group is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of AiN Group?AiN Group trades under 9627 ticker.
When did AiN Group go public?AiN Group went public in 2009.
Who are competitors of AiN Group?AiN Group main competitors are Create SD Holdings, Redcare Pharmacy, Selçuk Ecza, Yixintang Pharmaceutical.
What is the current market cap of AiN Group?AiN Group's current market cap is $1B.
What is the current revenue of AiN Group?AiN Group's last 12 months revenue is $4B.
What is the current revenue growth of AiN Group?AiN Group revenue growth (NTM/LTM) is 14%.
What is the current EV/Revenue multiple of AiN Group?Current revenue multiple of AiN Group is 0.4x.
Is AiN Group profitable?Yes, AiN Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of AiN Group?AiN Group's last 12 months EBITDA is $307M.
What is AiN Group's EBITDA margin?AiN Group's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of AiN Group?Current EBITDA multiple of AiN Group is 4.7x.
What is the current FCF of AiN Group?AiN Group's last 12 months FCF is ($623M).
What is AiN Group's FCF margin?AiN Group's last 12 months FCF margin is (16%).
What is the current EV/FCF multiple of AiN Group?Current FCF multiple of AiN Group is (2.3x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial